Jacob Langness

516 total citations
10 papers, 381 citations indexed

About

Jacob Langness is a scholar working on Infectious Diseases, Hepatology and Epidemiology. According to data from OpenAlex, Jacob Langness has authored 10 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Hepatology and 3 papers in Epidemiology. Recurrent topics in Jacob Langness's work include HIV/AIDS drug development and treatment (5 papers), Hepatitis C virus research (4 papers) and HIV/AIDS Research and Interventions (3 papers). Jacob Langness is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), Hepatitis C virus research (4 papers) and HIV/AIDS Research and Interventions (3 papers). Jacob Langness collaborates with scholars based in United States, Canada and Armenia. Jacob Langness's co-authors include Jennifer J. Kiser, José Castillo‐Mancilla, Lane R. Bushman, Amie L. Meditz, Jia‐Hua Zheng, Peter L. Anderson, Joseph E. Rower, Julie A. Predhomme, Edward M. Gardner and Gregory T. Everson and has published in prestigious journals such as Clinical Infectious Diseases, Nature Reviews Gastroenterology & Hepatology and World Journal of Gastroenterology.

In The Last Decade

Jacob Langness

10 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob Langness United States 7 305 163 127 48 45 10 381
Brandon Klein United States 9 356 1.2× 157 1.0× 177 1.4× 37 0.8× 32 0.7× 33 471
Louis Guida United States 7 242 0.8× 150 0.9× 117 0.9× 29 0.6× 28 0.6× 8 365
G. Friedland United States 11 315 1.0× 323 2.0× 169 1.3× 19 0.4× 52 1.2× 14 534
Maura Laverty United States 8 356 1.2× 181 1.1× 243 1.9× 18 0.4× 59 1.3× 15 517
Giovanni Ravasi United States 13 391 1.3× 202 1.2× 183 1.4× 27 0.6× 45 1.0× 29 453
Asghar Kheshti United States 9 282 0.9× 139 0.9× 138 1.1× 10 0.2× 64 1.4× 10 325
Tristan Barber United Kingdom 12 330 1.1× 163 1.0× 165 1.3× 15 0.3× 130 2.9× 56 467
Haswell Jere Italy 9 245 0.8× 132 0.8× 68 0.5× 23 0.5× 70 1.6× 18 330
M Fisher United Kingdom 8 335 1.1× 182 1.1× 244 1.9× 90 1.9× 91 2.0× 12 448
Mustafa E. Ibrahim United States 8 275 0.9× 122 0.7× 127 1.0× 9 0.2× 30 0.7× 12 361

Countries citing papers authored by Jacob Langness

Since Specialization
Citations

This map shows the geographic impact of Jacob Langness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Langness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Langness more than expected).

Fields of papers citing papers by Jacob Langness

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Langness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Langness. The network helps show where Jacob Langness may publish in the future.

Co-authorship network of co-authors of Jacob Langness

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Langness. A scholar is included among the top collaborators of Jacob Langness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Langness. Jacob Langness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Erlandson, Kristine M., Kellie L. Hawkins, Jacob Langness, et al.. (2018). Low Rates of Vaccination for Herpes Zoster in Older People Living With HIV. AIDS Research and Human Retroviruses. 34(7). 603–606. 10 indexed citations
2.
Langness, Jacob, et al.. (2017). Curing Chronic Hepatitis C: A Cost Comparison of the Combination Simeprevir Plus Sofosbuvir vs. Protease-Inhibitor-Based Triple Therapy. Annals of Hepatology. 16(3). 366–374. 3 indexed citations
3.
Langness, Jacob, et al.. (2017). Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions. World Journal of Gastroenterology. 23(9). 1618–1618. 38 indexed citations
4.
Langness, Jacob & Gregory T. Everson. (2016). Drug–drug interactions in HCV treatment — the good, the bad and the ugly. Nature Reviews Gastroenterology & Hepatology. 13(4). 194–195. 2 indexed citations
5.
Urban, Thomas, Shyam Kottilil, Eric G. Meissner, et al.. (2016). Variant Inosine Triphosphatase Phenotypes Are Associated With Increased Ribavirin Triphosphate Levels. The Journal of Clinical Pharmacology. 57(1). 118–124. 6 indexed citations
6.
7.
Linnebur, Sunny A., et al.. (2013). Priapism Induced by Boceprevir-CYP3A4 Inhibition and  -Adrenergic Blockade: Case Report. Clinical Infectious Diseases. 58(1). e35–e38. 7 indexed citations
8.
Zheng, Jia‐Hua, Louis Guida, José Castillo‐Mancilla, et al.. (2013). Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 88. 144–151. 53 indexed citations
9.
Castillo‐Mancilla, José, Jia‐Hua Zheng, Joseph E. Rower, et al.. (2012). Tenofovir, Emtricitabine, and Tenofovir Diphosphate in Dried Blood Spots for Determining Recent and Cumulative Drug Exposure. AIDS Research and Human Retroviruses. 29(2). 384–390. 239 indexed citations
10.
Langness, Jacob, Jason T. Hindman, Steven C. Johnson, & Jennifer J. Kiser. (2012). The Frequency of Adjusted Renal Dosing of Tenofovir DF and Its Effects on Patient Outcomes. Journal of Pharmacy Practice. 26(4). 397–400. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brandon Klein Breakdown of academic impact, for papers by Louis Guida Breakdown of academic impact, for papers by G. Friedland Breakdown of academic impact, for papers by Maura Laverty Breakdown of academic impact, for papers by Giovanni Ravasi Breakdown of academic impact, for papers by Asghar Kheshti Breakdown of academic impact, for papers by Tristan Barber Breakdown of academic impact, for papers by Haswell Jere Breakdown of academic impact, for papers by M Fisher Breakdown of academic impact, for papers by Mustafa E. Ibrahim
Rankless by CCL
2026